Bank Of America Corp Applied Therapeutics Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 314,906 shares of APLT stock, worth $192,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares

314,906

Previous 229,862 37.0%

Holding current value

$192,092

Previous $1.07 Million 149.39%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.35 - $8.5 $369,941 - $722,874	85,044 Added 37.0%	314,906 $2.68 Million
Q2 2024 Aug 14, 2024	BUY	$4.04 - $6.37 $785,040 - $1.24 Million	194,317 Added 546.68%	229,862 $1.07 Million
Q1 2024 May 15, 2024	SELL	$2.25 - $7.4 $20,443 - $67,236	-9,086 Reduced 20.36%	35,545 $241,000
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $82,119 - $149,510	44,630 Added 4463000.0%	44,631 $149,000
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.8 $280 - $655	-364 Reduced 99.73%	1 $0
Q1 2023 May 12, 2023	BUY	$0.75 - $1.21 $177 - $285	236 Added 182.95%	365 $0
Q4 2022 Feb 10, 2023	SELL	$0.54 - $1.12 $177 - $368	-329 Reduced 71.83%	129 $0
Q3 2022 Nov 14, 2022	SELL	$0.86 - $1.55 $3,383 - $6,097	-3,934 Reduced 89.57%	458 $0
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $12,004 - $41,701	-15,796 Reduced 78.24%	4,392 $4,000
Q1 2022 May 16, 2022	SELL	$1.48 - $6.22 $23,447 - $98,543	-15,843 Reduced 43.97%	20,188 $43,000
Q4 2021 Feb 08, 2022	BUY	$8.77 - $18.29 $188,449 - $393,015	21,488 Added 147.75%	36,031 $322,000
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $22,557 - $36,751	1,666 Added 12.94%	14,543 $242,000
Q2 2021 Sep 13, 2021	BUY	$14.05 - $25.04 $180,921 - $322,440	12,877 New	12,877 $268,000

Others Institutions Holding APLT

# of Institutions

143

Shares Held

111M

Call Options Held

1.68M

Put Options Held

1.91M

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $29.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Applied Therapeutics Inc. Transaction History